Daniel S. Lefler, MD
Assistant Professor of Clinical Medicine (Hematology-Oncology)
Assistant Program Director of the Hematology/Oncology Fellowhip Program, Hospital of the University of Pennsylvania
Associate Clinical Director of Sarcoma Medical Oncology, Abramson Cancer Center
Medical Director, PCAM 3
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
10-145 South Pavilion
Philadelphia, PA 19104
3400 Civic Center Blvd
10-145 South Pavilion
Philadelphia, PA 19104
Education:
BS (Neuroscience (Minor in Religious Studies))
The College of William & Mary, 2012.
MD (Medicine )
Cooper Medical School of Rowan University , 2016.
Permanent linkBS (Neuroscience (Minor in Religious Studies))
The College of William & Mary, 2012.
MD (Medicine )
Cooper Medical School of Rowan University , 2016.
Selected Publications
Daniel S Lefler, Andrew Elliott, Wei Jiang, Ubaldo Martinez-Outschoorn, Jude Al-Sabah, Daniel M Freed, Caitlin M King, Robert G Maki, Richard F Riedel, Jaime F Modiano, Daniel Hübschmann, Hanno Glimm, Stefan Fröhling, Matthew Oberley, Sosipatros A Boikos, Atrayee Basu Mallick: Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma. JCO Precis Oncol July 2025.Mohammad S Farooq, Neha Shafique, Gracia M Vargas, Jennifer Guo, John T Miura, Daniel S Lefler, Giorgos C Karakousis: Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis. J Surg Oncol June 2025.
Gabriel Aleixo, Lee Hartner, Mark Diamond, Lazlo Nziga, Daniel Lefler: Liposomal vs conventional doxorubicin as first-line therapy in advanced soft tissue sarcomas: A tertiary US center’s 8.5-year experience. 2025 ASCO Annual Meeting May 2025.
Lefler, D.S., Maki, R.G., Somaiah, N.,…Basu Mallick, A.: Characterizing the genomic landscape of perivascular epithelioid cell family of tumors in a real-world patient population using the Foundation Medicine genomic database. Connective Tissue Oncology Society Annual Meeting Nov 2024 Notes: Oral presentation.
Lefler, D.S., Moding, E.J., Basu Mallick, A: mTOR activity: a biomarker for chemo- and immunotherapy response and outcomes in sarcomas. Connective Tissue Oncology Society Annual Meeting Nov 2024 Notes: Poster.
Lefler, D.S., Elliott, A., Blomain, E.S.,…Basu Mallick, A: Characterizing patterns of mTORC1 activation across sarcomas using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database. ASCO Annual Meeting June 2024 Notes: Poster.
Jirka GW, Lefler DS, Russo J, Bashir B.: Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer Biol Ther Dec 2023.
Lefler DS, Manobianco SA, Bashir B.: Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer Biol Ther Dec 2023.
Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS: Liver Transplantation in a Woman with Mahvash Disease. N Engl J Med Nov 2023.
Lefler, D.S., Elliott, A., Maki, R.G.,…Basu Mallick, A.: Overexpression of cyclin dependent kinases and cyclins across sarcomas beyond CDK4. Connective Tissue Oncology Society Annual Meeting Nov 2023 Notes: Poster.